Construct: ORF TRCN0000492269

Construct Description:

Construct Type:
ORF
Other Identifiers:
ORF008710.1_s317c1
Derived from:
ccsbBroadEn_01534
DNA Barcode:
CGTGAGCGCATCGCAAAACCGGGC
Epitope Tag:
V5
Notes:
No stop codon in insert

Originally Annotated References:

Gene:
ST3GAL3 (6487)

Vector Information:

Vector Backbone:
pLX_317
Pol II Cassette 1:
SV40-PuroR
Pol II Cassette 2:
EF1a-TRCN0000492269
Selection Marker:
PuroR
Visible Reporter:
n/a
Epitope Tag:
n/a

Current transcripts matched by this ORF:

Taxon Gene Symbol Description Transcript Nuc. Match %[?] Prot. Match %[?] Match Diffs[?]
1 human 6487 ST3GAL3 ST3 beta-galactoside alpha-... NM_006279.5 100% 100%
2 human 6487 ST3GAL3 ST3 beta-galactoside alpha-... XM_017002113.1 100% 100%
3 human 6487 ST3GAL3 ST3 beta-galactoside alpha-... NM_174964.4 96.1% 95.8% 119_163del
4 human 6487 ST3GAL3 ST3 beta-galactoside alpha-... NM_174969.4 95.7% 95.4% 118_119ins48
5 human 6487 ST3GAL3 ST3 beta-galactoside alpha-... NM_001270459.2 92% 92% 743_744ins90
6 human 6487 ST3GAL3 ST3 beta-galactoside alpha-... NM_001270460.2 91.7% 91.7% 209_210ins93
7 human 6487 ST3GAL3 ST3 beta-galactoside alpha-... NM_174968.5 87.4% 87.4% 210_371del
8 human 6487 ST3GAL3 ST3 beta-galactoside alpha-... NM_174963.5 84.4% 84.2% 119_163del;255_416del
9 human 6487 ST3GAL3 ST3 beta-galactoside alpha-... NM_001350620.2 83.7% 77.1% 1039_1234del;1302_1303insTGATCTAAGCAGTGGCATC
10 human 6487 ST3GAL3 ST3 beta-galactoside alpha-... NM_174971.5 83.6% 83.4% 118_119ins48;162_323del
11 human 6487 ST3GAL3 ST3 beta-galactoside alpha-... NM_001350619.2 80.9% 74.4% 119_163del;1084_1279del;1347_1348insTGATCTAAGCAGTGGCATC
12 human 6487 ST3GAL3 ST3 beta-galactoside alpha-... XM_006710827.4 80% 73.3% 118_119ins48;991_1186del;1254_1255insTGATCTAAGCAGTGGCATC
13 human 6487 ST3GAL3 ST3 beta-galactoside alpha-... XM_011541974.2 74.5% 68.9% 210_371del;1201_1396del;1464_1465insTGATCTAAGCAGTGGCATC
14 human 6487 ST3GAL3 ST3 beta-galactoside alpha-... NM_174966.4 73.8% 73.8% 743_744ins294
15 human 6487 ST3GAL3 ST3 beta-galactoside alpha-... XM_011541973.2 73.4% 66.8% (many diffs)
16 human 6487 ST3GAL3 ST3 beta-galactoside alpha-... XM_017002109.2 72.3% 66.7% (many diffs)
17 human 6487 ST3GAL3 ST3 beta-galactoside alpha-... XM_017002120.1 71.4% 71.4% 0_1ins321
18 human 6487 ST3GAL3 ST3 beta-galactoside alpha-... XM_017002121.1 71.4% 71.4% 0_1ins321
19 human 6487 ST3GAL3 ST3 beta-galactoside alpha-... XM_011541976.2 71.3% 65.5% (many diffs)
20 human 6487 ST3GAL3 ST3 beta-galactoside alpha-... XM_011541980.3 70.1% 61% (many diffs)
21 human 6487 ST3GAL3 ST3 beta-galactoside alpha-... NM_001270461.3 69.6% 69.3% 118_119ins48;695_696ins294
22 human 6487 ST3GAL3 ST3 beta-galactoside alpha-... XM_017002110.1 64.6% 50.9% (many diffs)
23 human 6487 ST3GAL3 ST3 beta-galactoside alpha-... NM_001363573.2 64.5% 64.5% 210_371del;905_906ins294
24 human 6487 ST3GAL3 ST3 beta-galactoside alpha-... XM_011541981.2 62.3% 62.1% 119_163del;255_416del;950_951ins294
25 human 6487 ST3GAL3 ST3 beta-galactoside alpha-... XM_011541983.2 62.3% 56.3% 0_1ins282;757_952del;1020_1021insTGATCTAAGCAGTGGCATC
26 human 6487 ST3GAL3 ST3 beta-galactoside alpha-... XM_017002116.1 62.3% 56.3% 0_1ins282;757_952del;1020_1021insTGATCTAAGCAGTGGCATC
27 human 6487 ST3GAL3 ST3 beta-galactoside alpha-... NM_001350621.2 62.1% 54.9% (many diffs)
28 human 6487 ST3GAL3 ST3 beta-galactoside alpha-... XM_017002114.1 62.1% 54.9% (many diffs)
29 human 6487 ST3GAL3 ST3 beta-galactoside alpha-... XM_017002115.1 62.1% 54.9% (many diffs)
30 human 6487 ST3GAL3 ST3 beta-galactoside alpha-... NM_001270462.3 61.3% 61% 118_119ins48;161_162ins93;602_603ins294
31 human 6487 ST3GAL3 ST3 beta-galactoside alpha-... XM_011541987.2 59.4% 53.4% 0_1ins321;718_913del;981_982insTGATCTAAGCAGTGGCATC
32 human 6487 ST3GAL3 ST3 beta-galactoside alpha-... XM_011541988.2 59.4% 53.4% 0_1ins321;718_913del;981_982insTGATCTAAGCAGTGGCATC
33 human 6487 ST3GAL3 ST3 beta-galactoside alpha-... XM_011541984.2 57.5% 56.1% (many diffs)
34 human 6487 ST3GAL3 ST3 beta-galactoside alpha-... XM_011541985.2 57.5% 56.1% (many diffs)
35 human 6487 ST3GAL3 ST3 beta-galactoside alpha-... XM_011541986.3 57.5% 56.1% (many diffs)
36 human 6487 ST3GAL3 ST3 beta-galactoside alpha-... XR_946743.2 55% (many diffs)
37 human 6487 ST3GAL3 ST3 beta-galactoside alpha-... XR_001737368.1 54.6% (many diffs)
38 human 6487 ST3GAL3 ST3 beta-galactoside alpha-... XR_946744.2 54.2% (many diffs)
39 human 6487 ST3GAL3 ST3 beta-galactoside alpha-... XR_946742.2 52.8% (many diffs)
40 human 6487 ST3GAL3 ST3 beta-galactoside alpha-... NR_073016.3 49.2% 1_188del;744_775del;1346_2286del
41 human 6487 ST3GAL3 ST3 beta-galactoside alpha-... NM_001270463.3 48.5% 46.9% (many diffs)
42 human 6487 ST3GAL3 ST3 beta-galactoside alpha-... NR_073018.3 47.2% (many diffs)
43 human 6487 ST3GAL3 ST3 beta-galactoside alpha-... NM_001270464.3 47% 46% (many diffs)
44 human 6487 ST3GAL3 ST3 beta-galactoside alpha-... NM_001270465.2 46.7% 46% (many diffs)
45 human 6487 ST3GAL3 ST3 beta-galactoside alpha-... NR_073017.3 45.8% 1_188del;306_307ins91;1223_2163del
46 human 6487 ST3GAL3 ST3 beta-galactoside alpha-... NR_146867.2 45.3% (many diffs)
47 human 6487 ST3GAL3 ST3 beta-galactoside alpha-... XR_946745.2 44.9% (many diffs)
48 human 6487 ST3GAL3 ST3 beta-galactoside alpha-... NR_073019.3 41.1% (many diffs)
49 human 6487 ST3GAL3 ST3 beta-galactoside alpha-... NR_073020.3 39.4% (many diffs)
50 human 6487 ST3GAL3 ST3 beta-galactoside alpha-... NM_174967.4 39.1% 36.8% (many diffs)
51 human 6487 ST3GAL3 ST3 beta-galactoside alpha-... NM_174965.3 37.6% 35.2% (many diffs)
52 human 6487 ST3GAL3 ST3 beta-galactoside alpha-... NM_174970.4 34.8% 32.3% (many diffs)
53 human 6487 ST3GAL3 ST3 beta-galactoside alpha-... NR_073023.3 34.5% 1_188del;584_585ins347;967_1907del
54 human 6487 ST3GAL3 ST3 beta-galactoside alpha-... NM_001270466.2 25.1% 23.4% (many diffs)
55 mouse 20441 St3gal3 ST3 beta-galactoside alpha-... NM_001161774.2 91.9% 97% (many diffs)
56 mouse 20441 St3gal3 ST3 beta-galactoside alpha-... NM_001285520.1 91.9% 97% (many diffs)
57 mouse 20441 St3gal3 ST3 beta-galactoside alpha-... NM_009176.5 91.9% 97% (many diffs)
58 mouse 20441 St3gal3 ST3 beta-galactoside alpha-... NM_001285521.1 88% 93.3% (many diffs)
59 mouse 20441 St3gal3 ST3 beta-galactoside alpha-... XM_006502898.3 88% 93.3% (many diffs)
60 mouse 20441 St3gal3 ST3 beta-galactoside alpha-... XM_006502896.3 86.8% 91.6% (many diffs)
61 mouse 20441 St3gal3 ST3 beta-galactoside alpha-... XM_006502894.1 85.5% 90.3% (many diffs)
62 mouse 20441 St3gal3 ST3 beta-galactoside alpha-... XM_006502895.1 85.5% 90.3% (many diffs)
63 mouse 20441 St3gal3 ST3 beta-galactoside alpha-... XM_006502897.3 81.9% 86.8% (many diffs)
64 mouse 20441 St3gal3 ST3 beta-galactoside alpha-... XM_006502893.3 81.8% 86.5% (many diffs)
65 mouse 20441 St3gal3 ST3 beta-galactoside alpha-... XM_006502890.3 81% 85.6% (many diffs)
66 mouse 20441 St3gal3 ST3 beta-galactoside alpha-... XM_006502891.3 81% 85.6% (many diffs)
67 mouse 20441 St3gal3 ST3 beta-galactoside alpha-... XM_006502892.3 81% 85.6% (many diffs)
68 mouse 20441 St3gal3 ST3 beta-galactoside alpha-... XM_006502899.3 61.9% 60.2% (many diffs)
69 mouse 20441 St3gal3 ST3 beta-galactoside alpha-... XR_376301.3 39.3% (many diffs)
70 mouse 20441 St3gal3 ST3 beta-galactoside alpha-... XR_376302.3 38.5% (many diffs)
Download CSV

Sequence Information

Note: uppercase bases indicate empirically verified sequence.

ORF start:
66
ORF end:
1191
ORF length:
1125
Sequence:
1tcttccattt caggtgtcgt gaggctagca tcgattgatc aacaagtttg tacaaaaaag
61ttggcatggg actcttggta tttgtgcgca atctgctgct agccctctgc ctctttctgg
121tactgggatt tttgtattat tctgcgtgga agctacactt actccagtgg gaggaggact
181ccaattcagt ggttctttcc tttgactccg ctggacaaac actaggctca gagtatgatc
241ggttgggctt cctcctgaat ctggactcta aactgcctgc tgaattagcc accaagtacg
301caaacttttc agagggagct tgcaagcctg gctatgcttc agccttgatg acggccatct
361tcccccggtt ctccaagcca gcacccatgt tcctggatga ctcctttcgc aagtgggcta
421gaatccggga gttcgtgccg ccttttggga tcaaaggtca agacaatctg atcaaagcca
481tcttgtcagt caccaaagag taccgcctga cccctgcctt ggacagcctc cgctgccgcc
541gctgcatcat cgtgggcaat ggaggcgttc ttgccaacaa gtctctgggg tcacgaattg
601acgactatga cattgtggtg agactgaatt cagcaccagt gaaaggcttt gagaaggacg
661tgggcagcaa aacgacactg cgcatcacct accccgaggg cgccatgcag cggcctgagc
721agtacgagcg cgattctctc tttgtcctcg ccggcttcaa gtggcaggac tttaagtggt
781tgaaatacat cGTCTACAAG GAGAGAGTGA GTGCATCGGA TGGCTTCTGG AAATCTGTGG
841CCACTCGAGT GCCCAAGGAG CCCCCTGAGA TTCGAATCCT CAACCCATAT TTCATCCAGG
901AGGCCGCCTT CACCCTCATT GGCCTGCCCT TCAACAATGG CCTCATGGGC CGGGGGAACA
961TCCCTACCCT TGGCAGTGTG GCAGTGACCA TGGCACTACA CGGCTGTGAC GAGGTGGCAG
1021TCGCAGGATT TGGCTATGAC ATGAGCACAC CCAACGCACC CCTGCACTAC TATGAGACCG
1081TTCGCATGGC AGCCATCAAA GAGTCCTGGA CGCACAATAT CCAGCGAGAG AAAGAGTTTC
1141TGCGGAAGCT GGTGAAAGCT CGCGTCATCA CTGATCTAAG CAGTGGCATC TGCCCAACTT
1201TCTTGTACAA AGTGGTTGAT ATCGGTAAGC CTATCCCTAA CCCTCTCCTC GGTCTCGATT
1261CTACGTAGTA ATGAACTAGT CCGTAACTTG AAAGTATTTC GATTTCTTGG CTTTATATAT
1321CTTGTGGAAA GGACGACGTG AGCGCATCGC AAAACCGGGC ACGCGTTAAG TCgacaatca
1381acctctggat tacaaaattt gtgaaagatt

Download FASTA (ORF) (Full)

GPP Web Portal Terms of Service

Effective Date: December 8, 2025
By using this site, you agree to our terms and conditions below.

Overview of Terms

The data made available on this website were generated for research purposes and are not intended for clinical or commercial uses. Commercial use (or other use for profit-making purposes) of the GPP Web Portal and its tools, is not permitted under these terms and may require a separate license agreement from Broad or its contributors. For more information, please contact partnering@broadinstitute.org.

The original data may be subject to rights claimed by third parties, including but not limited to, patent, copyright, other intellectual property rights, biodiversity-related access and benefit-sharing rights. It is the responsibility of users of Broad Institute services to ensure that their use of the data does not infringe any of the rights of such third parties.

Any questions or comments concerning these Terms of Use can be addressed to: legal@broadinstitute.org.

By accessing and viewing this GPP Web Portal, you agree to the following terms and conditions:

Attribution

You agree to acknowledge the Broad Institute (e.g., in publications, services or products) for any of your use of its online services, databases or software in accordance with good scientific practice. You agree to use the acknowledgment wording provided for the relevant tools as indicated on the FAQ for each tool.

Updating the Terms of Use

We reserve the right to update these Terms of Use at any time. When alterations are inevitable, we will attempt to give reasonable notice of any changes by placing a notice on our website, but you may wish to check each time you use the website. The date of the most recent revision will appear on this, the "GPP Web Portal Terms of Use" page. If you do not agree to these changes, please do not continue to use our online services. We will also make available an archived copy of the previous Terms of Use for comparison.

Indemnification and Disclaimer of Warranties

You are using this GPP Web Portal at your own risk, and you hereby agree to hold Broad and its contributors and their trustees, directors, officers, employees, and affiliated investigators harmless for any third party claims which may arise from your use of the GPP Web Portal, the tools available therein, or any portion thereof. Further, you agree to indemnify Broad, its contributors, and its and their trustees, directors, officers, employees, affiliated investigators, students, and affiliates for any loss, costs, claims, damages, or other liabilities arising from any unpermitted commercial or profit-making use you make of the GPP Web Portal. The GPP Web Portal is a research tool and is provided "as is". Broad does not represent that the GPP Web Portal is free of errors or bugs or suitable for any particular tasks.

ANY EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, THE IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NONINFRINGEMENT, OR THE ABSENCE OF LATENT OR OTHER DEFECTS ARE DISCLAIMED. IN NO EVENT SHALL BROAD OR ITS CONTRIBUTORS BE LIABLE FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, EXEMPLARY, OR CONSEQUENTIAL DAMAGES HOWEVER CAUSED AND ON ANY THEORY OF LIABILITY, WHETHER IN CONTRACT, STRICT LIABILITY, OR TORT (INCLUDING NEGLIGENCE OR OTHERWISE) ARISING IN ANY WAY OUT OF THE USE OF THE GPP WEB PORTAL, EVEN IF ADVISED OF THE POSSIBILITY OF SUCH DAMAGE.

Governing Law

The terms and conditions herein shall be construed, governed, interpreted, and applied in accordance with the internal laws of the Commonwealth of Massachusetts, U.S.A. Furthermore, by accessing, downloading, or using the Database, You consent to the personal jurisdiction of, and venue in, the state and federal courts within Massachusetts with respect to Your download or use of the Database.